Dr. Putcha on the Utility of Blood-Based Assays in CRC

Article

Girish Putcha, MD, PhD, discusses the utility of blood-based assays in colorectal cancer.

Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director, Freenome, discusses the utility of blood-based assays in colorectal cancer (CRC).

The AI EMERGE trial (NCT03688906) compared mutation detection based on circulating tumor (ct)DNA and a carcinoembryonic antigen (CEA)-based classifier and showed that a multiomic blood-based screening assay had higher sensitivity and specificity versus singular tumor-based assays in detecting early-stage colorectal cancer, says Putcha.

The sensitivity of the blood-based test was about 90% versus 47% with the ctDNA-based assay, and the specificity was 100% versus 75%, respectively. Furthermore, the sensitivity for the blood-based test was 91% compared to 31% with the CEA-based assay with a specificity of 94% for both assays. These results show that the multiomic approach holds promise for detecting disease in patients with early-stage CRC, concludes Putcha.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Michael Leung, PharmD, an expert on colorectal cancer
A panel of 4 experts on colorectal cancer